A Comparison of Meal Replacements and Medication in Weight Maintenance after Weight Loss
The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: To compare the use of meal replacements or medication during weight maintenance subsequent to weight loss using a very low-energy diet (VLED) in overweight or obese adults. DESIGN: Participants followed a liquid VLED of 2177 kJ for 12 weeks followed by 4 weeks of re-orientation to solid foods. Participants were randomized at week 16 to receive either meal replacements or Orlistat both combined with a structured meal plan containing an energy value calculated to maintain weight loss. SUBJECTS: Sixty-four women (age = 49.9 +/- 10 y, weight = 101.6 +/- 17.1 kg, height = 164.9 +/- 6.0 cm, BMI = 36.7 +/- 5.4 kg/m(2)) and 28 men (age = 53.7 +/- 9.6 y, weight = 121.8 +/- 16.0 kg, height = 178.7 +/- 5.6 cm, BMI = 37.8 +/- 4.9 kg/m(2)) completed a 1 year weight management program. Behavioral weight management clinics included topics on lifestyle, physical activity (PA), and nutrition. Participants met for 90 min weekly for 26 weeks, and then biweekly for the remaining 26 weeks. OUTCOMES: Minutes of PA, fruits and vegetables (FV), and pedometer steps were recorded on a daily basis and reported at each group meeting. Body weight was obtained at each group meeting. RESULTS: During VLED, the MR group decreased body weight by 22.8 +/- 6.1 kg and the Orlistat group decreased body weight by 22.3 +/- 6.1 kg. During weight maintenance, there was no significant group by time interaction for body weight, PA, FV consumption, or pedometer steps. At week 16, the meal replacement group had a body weight of 85.4 +/- 14.3 kg that increased to 88.1 +/- 16.5 kg at 52 weeks (p < 0.05). At week 16, the Orlistat group had a body weight of 85.7 +/- 17.9 kg that increased to 88.5 +/- 20.3 kg at 52 weeks (p < 0.05). CONCLUSIONS: Subsequent to weight loss from a VLED, meal replacements and Orlistat treatments were both effective in maintaining weight significantly below baseline levels over a 52 week period of time. Meal replacements may be a viable alternative strategy to medications for weight maintenance.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Long-term maintenance of weight loss: Current status.
Jeffery, R. W., Epstein, L. H., Wilson, G. T., Drewnowski, A., Stunkard, A. J., & Wing, R. R. (2000) · Health Psychology · doi:10.1037/0278-6133.19.suppl1.5 · Cited by 1,093 · cited 1×
“treatment, extending the length of treatment, altering dietary and exercise prescriptions, enhancing motivation, and teaching maintenance behavioral skills [10].”
BackgroundEffects of weight reduction on blood lipids and lipoproteins: a meta-analysis
Dattilo, A., & Kris-Etherton, P. (1992) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/56.2.320 · Cited by 1,055
Davidson, M. H., Hauptman, J., DiGirolamo, M., Foreyt, J. P., Halsted, C. H., Heber, D., Heimburger, D. C., Lucas, C. P., Robbins, D. C., Chung, J., et al. (1999) · JAMA · doi:10.1001/jama.281.3.235 · Cited by 947 · cited 1×
“Various studies have indicated that gastrointestinal adverse effects occur more frequently with Orlistat when compared to placebo [15,16].”
BackgroundWeight management using a meal replacement strategy: meta and pooling analysis from six studies.
Heymsfield, S. B., van Mierlo, C. A. J., van der Knaap, H. C. M., Heo, M., & Frier, H. I. (2003) · International Journal of Obesity · doi:10.1038/sj.ijo.0802258 · Cited by 557 · cited 3×
“In addition, they are relatively inexpensive, convenient, and palatable [18].”
BackgroundRössner, S., Sjöström, L., Noack, R., Meinders, A. E., Noseda, G., & Study, O. B. O. T. E. O. O. (2000) · Obesity Research · doi:10.1038/oby.2000.8 · Cited by 476 · cited 2×
“FDA approved medications have shown increased weight maintenance compared to standard meal plans and behavioral therapy, but these medications may have undesirable side effects [14,20].”
BackgroundLong-term pharmacotherapy for obesity and overweight
Padwal, R. S., Rucker, D., Li, S. K., Curioni, C., & Lau, D. C. (2003) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004094.pub2 · Cited by 384
Pretreatment predictors of attrition and successful weight management in women
Teixeira, P. J., Going, S. B., Houtkooper, L. B., Cussler, E. C., Metcalfe, L. L., Blew, R. M., Sardinha, L. B., & Lohman, T. G. (2004) · International Journal of Obesity · doi:10.1038/sj.ijo.0802727 · Cited by 371 · cited 1×
“The 1 year attrition rate of the present study is similar to other investigations [32,33].”
ResultOrlistat in the long-term treatment of obesity in primary care settings.
Hauptman, J. (2000) · Archives of Family Medicine · doi:10.1001/archfami.9.2.160 · Cited by 367 · cited 1×
“Various studies have indicated that gastrointestinal adverse effects occur more frequently with Orlistat when compared to placebo [15,16].”
BackgroundOrlistat, a lipase inhibitor, for weight maintenance after conventional dieting: a 1-y study.
Hill, J. O., Hauptman, J., Anderson, J. W., Fujioka, K., O'Neil, P. M., Smith, D. K., Zavoral, J. H., & Aronne, L. J. (1999) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/69.6.1108 · Cited by 287 · cited 1×
“In the present study, approximately 41% of participants reported gastrointestinal problems related to the medication whereas others have reported slightly higher frequency of adverse events [14,27].”
BackgroundA systematic review of the clinical effectiveness of orlistat used for the management of obesity
O'Meara, S., Riemsma, R., Shirran, L., Mather, L., & Ter Riet, G. (2004) · Obesity Reviews · doi:10.1111/j.1467-789x.2004.00125.x · Cited by 103 · cited 1×
“Differences for weight gain between medication and conventional diets range from 3% to almost 30% [26].”
Background
Cited by
Randomized Clinical Trials of Weight Loss Maintenance: A Review
Turk, M. W., Yang, K., Hravnak, M., Sereika, S. M., Ewing, L. J., & Burke, L. E. (2009) · Journal of Cardiovascular Nursing · doi:10.1097/01.jcn.0000317471.58048.32 · Cited by 258
Outcomes of a weight loss intervention among rural breast cancer survivors
Befort, C. A., Klemp, J. R., Austin, H. L., Perri, M. G., Schmitz, K. H., Sullivan, D. K., & Fabian, C. J. (2012) · Breast Cancer Research and Treatment · doi:10.1007/s10549-011-1922-3 · Cited by 138
“that rely completely on individuals preparing all their own meals [20–23], as well as greater adherence and nutrition 632 Breast Cancer Res Treat (2012) 132:631–639”
BackgroundGroup versus individual phone-based obesity treatment for rural women
Befort, C. A., Donnelly, J. E., Sullivan, D. K., Ellerbeck, E. F., & Perri, M. G. (2010) · Eating Behaviors · doi:10.1016/j.eatbeh.2009.08.002 · Cited by 105
Self-citation
Metadata
- Authors
- LeCheminant, J. D., Jacobsen, D. J., Hall, M. A., & Donnelly, J. E.
- Venue
- Journal of the American College of Nutrition
- Publisher
- Informa UK Limited
- Published
- 2005-10
- Volume
- 24
- Issue
- 5
- Pages
- 347-353
- ISSN
- 0731-5724 (ISSN-L)
- 1541-1087
- OpenAlex
- W2008023406
- Cited by
- 45
- References
- 10
- FWCI
- 1.72
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A Comparison of Meal Replacements and Medication in Weight Maintenance after Weight Loss. https://app.cochat.ai/papers/10.1080/07315724.2005.10719484
- The paper
- LeCheminant, J. D., Jacobsen, D. J., Hall, M. A., & Donnelly, J. E. (2005). A Comparison of Meal Replacements and Medication in Weight Maintenance after Weight Loss. Journal of the American College of Nutrition. https://doi.org/10.1080/07315724.2005.10719484
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.